Washington University School of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).
Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.
Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.
Top-decile sponsor footprint
Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,502 total, page 21 of 31
Effects of Obesity and Physical Inactivity on Pregnancy Outcomes
NCT02039414
Actinic Keratosis Study
NCT02019355
Diet and Exercise Intervention in Type 2 Diabetes
NCT01977560
Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients
NCT02012465
Tauroursodeoxycholic Acid for Protease-inhibitor Associated Insulin Resistance
NCT01877551
Disseminating Public Health Evidence to Support State Health Department Prevention of Cancer and Other Chronic Diseases
NCT01978054
Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant
NCT01928199
MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme
NCT01851733
LumaENT and Patient Satisfaction
NCT02611622
Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR) Treatment Approach for Stroke
NCT01910454
LAAM-HAART PET Imaging
NCT01935830
Innovative Model of Patient-Centered ConTraception
NCT02364037
The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease
NCT01971593
Can Intermittent Fasting Mimic the Metabolic and Cardiovascular and Anti-aging Effects of Calorie Restriction?
NCT01964118
Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT01716416
Randomized Clinical Trial of Skin Closure With Staples Versus Suture
NCT01977612
Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging
NCT02311556
Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies
NCT01677559
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors
NCT01784861
Dominican Republic Mission Cost Analysis
NCT01872364
Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers
NCT01806415
Vaginal Progesterone for the Prevention of Preterm Birth in Women With Arrested Preterm Labor
NCT01840228
Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma
NCT02584413
Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation
NCT01747499
Methadone in Pediatric Anesthesiology II
NCT01990573
Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation Therapy
NCT01821768
Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
NCT01999270
Individualized vs. Household MRSA Decolonization
NCT01814371
Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer
NCT01722162
Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction
NCT01969448
The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion
NCT01951729
Role of Neutrophil Activation
NCT01815229
Lipid Biomarkers for Diabetic Heart Disease
NCT01752842
Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation
NCT01700751
Genomic Predictors of Decitabine Response in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
NCT01687400
A Double Blind Clinical Trial of DCS for Food Anxiety
NCT01996644
Early Warning System
NCT01741480
Evaluation of PET/MRI in Patients With Pancreatic Adenocarcinoma
NCT02028377
GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer
NCT01553851
Exercise and Parkinson's: Comparing Interventions and Exploring Neural Mechanisms
NCT01768832
MRI for Non-invasive Evaluation of Brain Stress
NCT01898650
Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer
NCT01687413
Cemented vs Cementless TKA
NCT03683992
Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson
NCT01779869
Clinical Effectiveness of Self-Management Education Post-Mild Stroke
NCT01770184
Preferred Consent Models for Secondary Uses of Biospecimens Among Diverse Women
NCT02205749
Glyburide Healthy Volunteer Study
NCT01716338
Dose Escalation Trial of Intrasite Vancomycin Pharmacokinetics
NCT01764750
Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
NCT01670877
Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings
NCT01755000
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 332 |
| Phase 2 | 237 |
| Phase 3 | 40 |
| Phase 4 | 58 |
Therapeutic Areas
What is open in the Washington University School of Medicine pipeline
214 recruiting of 1,502 indexed (14% open); 919 completed (61%).
Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).
Top condition: Obesity (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Washington University School of Medicine: open-pipeline peers nationwide
Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,502 trials (± recruiting share)
- Yale University · 1,492 trials · 17% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Washington University School of Medicine page
1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.
- 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.